Liberal ‘Evening News’ Blames Drug Industry for TB Scare?

Question by GREAT_AMERICAN: Liberal ‘Evening News’ Blames Drug Industry for TB Scare?
‘Evening News’ Blames Drug Industry for TB Scare
CBS reporter cites lack of vaccine development but excludes industry rebuttal.

The tuberculosis scare led all three major network news broadcasts on May 31. But CBS “Evening News” pointed fingers at one of the network’s favorite targets, the pharmaceutical industry.

Reporter Nancy Cordes compared the lack of vaccinations and treatments of this specific strain of tuberculosis to other “fast-moving infectious diseases,” including SARS, West Nile Virus and Avian Flu.

She followed with the blame game. “Why haven’t more drugs been developed to fight disease with the potential to kill thousands?” asked Cordes, the network’s Transportation and Consumer Safety correspondent.

“Pharmaceutical companies live to make a profit and if antibiotics, for example, because they’re used for usually 7 to 14 days, maybe as long as a month, can’t generate the same kind of profits as a new cholesterol agent or the new Viagra, which a person might take for years,” said Dr. Eric Nuermberger, an assistant professor of Medicine, Division of Infectious Diseases, at Johns Hopkins School of Public Health.

The Associated Press reported that only two other patients with this drug-resistant strain of tuberculosis have been treated at National Jewish Hospital since 2000. With only three cases documented in the last seven years, it would be difficult for the pharmaceutical industry have developed vaccination and treatment for this specific strain. That was a point CBS did not make.

The CBS story also neglected to include a response from the pharmaceutical industry about its development of medications for infectious diseases.

However, Pharmaceutical Research and Manufacturers of America (PHRMA) points out such products are not that easy to develop. There are various hurdles that must be cleared. PHRMA stated new medicines used to treat these diseases “are the result of medical research and development that can take as long as 15 years and cost nearly $ 1 billion to bring a new medicine from the laboratory to a pharmacy shelf.”

A Business & Media Institute study found while covering everything from medical “controversies” to breakthroughs, nearly 80 percent of the stories excluded the viewpoint of the pharmaceutical industry, failing to include either a company statement or a company spokesman.

Best answer:

Answer by Matt
i would have thought they would blame bush first, then everyone else next

Know better? Leave your own answer in the comments!

OETA Story on Meth Madness #1 aired on 12/01/09 – This story aired on the Oklahoma News Report (ONR) on OETA-The Oklahoma Network. The reporter is Lis Exon; photojournalist is Tim Carson. For more information, go to the ONR web site www.news.oeta.tv and ONR blog blog.oeta.tv For more about OETA-The Oklahoma Network, visit www.oeta.tv EVEN BEFORE THE CURRENT STATE BUDGET CRISIS THE DEPARTMENT OF MENTAL HEALTH AND SUBSTANCE ABUSE WAS IN A FINANCIAL CRISIS. MENTAL HEALTH COMMISSIONER TERRI WHITE SAYS ONLY 23 PERCENT OF PEOPLE SEEKING ADDICTION TREATMENT CAN BE HELPED LEAVING THE MAJORITY TO FEND FOR THEMSELVES. IN A SERIES OF REPORTS THIS WEEK WE EXAMINE WHAT HAS TURNED OUT TO BE A LARGELY FAILING EFFORT TO TREAT OKLAHOMA’S METH ADDICITION. OETA’S LIS EXON HAS PART ONE OF METH MADNESS.

TB patient charged in Calif. for not taking meds

Filed under: drug treatment news stories

Many people have a latent form, and the active form usually only affects adults whose immune systems are compromised, which can happen from drug use. Public health experts are divided on the issue of mandatory treatment and criminal charges for …
Read more on USA TODAY

Antipsychotic medication relieves chemo-related nausea

Filed under: drug treatment news stories

By Liz Szabo, USA TODAY New research presented Wednesday highlights drugs to make cancer therapy easier but also underscores the difficulties that patients may encounter after treatment. Renee Nicholas, 37, had a double mastectomy after being diagnosed …
Read more on USA TODAY

MorphoSys to Present MOR208 Preclinical Combination Therapy Data at ASCO Meeting

Filed under: drug treatment news stories

Synergistic Effects Seen with Four Approved Treatment Options Including Rituximab and Ofatumumab MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced promising pre-clinical data on its proprietary drug candidate MOR208.
Read more on Reuters